WO1998054306A1 - Method for isolating an intracellular substance - Google Patents

Method for isolating an intracellular substance Download PDF

Info

Publication number
WO1998054306A1
WO1998054306A1 PCT/FR1998/001098 FR9801098W WO9854306A1 WO 1998054306 A1 WO1998054306 A1 WO 1998054306A1 FR 9801098 W FR9801098 W FR 9801098W WO 9854306 A1 WO9854306 A1 WO 9854306A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic
fraction
sample
cell
lysis
Prior art date
Application number
PCT/FR1998/001098
Other languages
French (fr)
Inventor
Lyse Santoro
Patrick Broyer
Bruno Mougin
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux filed Critical Bio Merieux
Priority to AU80242/98A priority Critical patent/AU8024298A/en
Publication of WO1998054306A1 publication Critical patent/WO1998054306A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • C12N1/066Lysis of microorganisms by physical methods
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Definitions

  • the present invention relates to a method for isolating intracellular, nucleic and / or protein material, from a cell sample suspended in a liquid, comprising a cell lysis step and a separation step.
  • the process of the invention is simple to implement, is suitable for any cell, eukaryotic cell, prokaryotic cell, in particular Gram + or Gram - bacteria, whatever the nature and the resistance of the cell envelope, and makes it possible to '' Direct access to the intracellular material without the need for an additional purification step.
  • the Applicant has discovered, completely unexpectedly, that the exposure of a cell sample to an electric pulse, under determined reaction conditions, leads to cell lysis with maximum yield, while liberating intracellular constituents in a form directly exploitable in a subsequent stage of treatment, in particular separation.
  • this technique consists in applying an electric field of an intensity greater than the dielectric force of the cell membrane, resulting in a modification of its conductivity and therefore of its permeability. Provided that it operates under substantially isotonic conditions so that an osmotic pressure of the same order exists between the interior and the exterior of the cell, this structural transformation of the membrane is reversible, and when the suspension is no longer subjected as a result of the electric field, the pores close up, trapping the exogenous substances that have entered.
  • Each species of cell has an optimal value for the electric field. The latter depends directly on the resistance and the constitution of the cell wall. It should be noted that a field of too high intensity causes the formation of pores of such a size that they can no longer close, and thus causes the death of the cell.
  • Patent application WO 91/18103 discloses a method for making cell membranes permeable in order to make molecules penetrate inside.
  • the method consists in emitting two successive short-duration rectangular type discharges, the first of 400 to 25,000 V / cm, of a duration of 10 ⁇ s to 10 ms and of capacity 40 ⁇ F, the second from 50 to 1000 V / cm with a duration of 1 ms to 1 s, with a capacity of 1800 ⁇ F.
  • the two electrical impulses must follow each other in a very short period of time, less than 10 s, so that the cell mortality rate is not too high.
  • Patent application WO 88/02777 discloses a method of extracting cellular content of any origin while preserving the cellular structure by the application of several short electrical discharges, of a duration between 1 ns and 1 ms, with an electric field varying from 100 to 15000 V / cm.
  • US Patent 5,326,530 discloses a method for killing bacteria present in a contaminated product.
  • the process consists in irreversibly breaking the membranes of bacteria by applying electrical impulses of the order of at least a few hundred at 10,000 V / cm for an extremely short period of between 0.2 and 200 ⁇ s.
  • a method allowing in a very short time to lyse all the cells from a suspension, whatever the cell concentration, that is to say even for high concentrations, in order to isolate an intracellular nucleic and / or protein material, which is separated and which, after separation, is liable to be directly subjected to a processing step.
  • This process for isolating intracellular nucleic and / or protein material, from a cell sample suspended in a liquid comprises the steps of:
  • the sample is exposed to at least one electrical pulse, at least one characteristic of which is determined to allow partial or complete lysis of the cells; a nucleic fraction and / or a protein fraction are separated from the lysed cells, and is characterized in that:
  • the duration of the electrical pulse defined by the time interval during which the electrical voltage is at least equal to 50% of the maximum voltage, is at least equal to 200 ms
  • the nucleic fraction may be subjected directly to at least one processing step.
  • isolation of an intracellular material is understood the separation, according to a specific or aspecific isolation method, qualitatively and / or quantitatively.
  • the method is applied to the isolation of nucleic material, but of course, this particular implementation does not introduce any limitation to this material.
  • the intracellular material to be isolated can consist of a protein fraction.
  • cell sample any sample capable of containing cells, in particular a biological sample such as that obtained from a biological fluid, a sample of food origin.
  • the sample consists of all or part of a sample, in particular it can consist of an aliquot, a dilution.
  • partial or complete lysis of cells By “partial or complete lysis of cells” according to the invention, it is understood that the membranes and / or wall of the cells present in the cell sample are irreversibly lysed, so as to release the intacellular material which one wishes to isolate and then treat .
  • the isolated intracellular material can be, without additional purification step, subjected to a processing step useful for detecting and / or identifying a component of the fraction of the isolated intracellular material.
  • an electrical pulse is defined as a significant contribution of electrical energy over a short period.
  • the duration of the pulse can in particular be determined by the capacity and / or the electrical resistance of an electrical charging circuit.
  • the capacitance has a value at least equal to 500 ⁇ F, preferably at least equal to 950 ⁇ F, and / or the resistance has a value at least equal to 50 Ohms.
  • a characteristic of the electric pulse is advantageously determined to establish in the sample an electric field at least equal to 2500 V / cm.
  • the characteristics of the electrical pulse to be applied to the cell sample to cause lysis according to the invention can be achieved by means of an electric generator recommended for the electroporation technique, although the range of values of the characteristics according to the invention lies outside the field of those used in electroporation.
  • the liquid in which the cell sample is in suspension is preferably water.
  • the intracellular material to be isolated is a nucleic acid material, and separating the nucleic material 'by contacting the lysed cell sample with a protease or a compound releasing organic radicals .
  • the protease or said reagent can be introduced initially into the cell sample, during or after step (a) of lysis.
  • the protease is in particular chosen from pronase, subtilysins, pepsin, trypsin, lysozyme, chymotrypsin, 1 ' ⁇ -chymotrypsin and proteinase K.
  • proteinase K is used.
  • the concentration of proteinase K in the The sample is between 0.5 and 9 mg / ml, preferably between 3 to 6 mg / ml, and more preferably, the concentration is equal to 6 mg / ml.
  • a radical-releasing compound useful for separating nucleic material is a compound which can produce, under certain conditions such as exposure to a source of light, thermal energy, or under certain chemical conditions, a radical carrying at least one free electron , very unstable and very reactive.
  • a preferred compound is a per-compound, in particular chosen from periodate, paraperiodate, sodium peroxide, perborate and for example sodium perborate tetrahydrate.
  • the processing step is a step of detecting at least one component of the nucleic fraction or a step of amplifying at least one component of the nucleic fraction.
  • the lysis step (a) leads to at least partial denaturation, or even fragmentation, of the nucleic material to be treated.
  • the method of the invention can also make it possible to recover intact intracellular material.
  • intact is meant material that is substantially undenatured and unfragmented.
  • an electrical pulse determined by a capacity of 500 ⁇ F, a resistance of 186 Ohms and an electrical voltage of 500 V. The present invention is illustrated below in the following examples 1 to 3, with reference to FIGS. 1 to 6.
  • Figure 1 represents the percentage of cell lysis as a function of the capacitance of the capacitor, for two values of the voltage of 2.5 kV and 0.45 kV respectively, and a resistance of 186 Ohms.
  • Figure 2 represents the percentage of cell lysis as a function of the capacitance of the capacitor, for a voltage of 500 V and a resistance of 186 Ohms.
  • Figure 3 shows the percentage of cell lysis as a function of the capacitance of the capacitor, for two values of the distance between the electrodes respectively, for a voltage of 500 V and a resistance of 186 Ohms.
  • FIG. 4 represents the percentage of cell lysis as a function of the resistance of the capacitor, for three values of the capacity respectively, and for a voltage of 500 V.
  • FIG. 5 represents the percentage of cell lysis as a function of the capacity of the capacitor, for two values of the volume of the cell suspension respectively, for a voltage of 500 V and a resistance of 186 Ohms.
  • FIG. 6 represents the percentage of detection of nucleic acids as a function of the electrical pulse, and more particularly of the capacity of the capacitor producing the pulse, for a voltage of 500 V and a resistance of 186 Ohms.
  • Gram-walled bacteria Staphylococcus epidermidis (strain A054) grown in BBC liquid medium (Brain Heart Brain) are centrifuged at 2500 rpm for 10 minutes, before being resuspended in water at a concentration of 3.3 ⁇ 10 ⁇ cells / ml.
  • 300 ⁇ l of the suspension are placed in an electroporation tank characterized by a distance between the two electrodes of 2 mm or 4 mm.
  • the tank is placed on an electrical circuit whose electrical parameters are chosen as follows:
  • variable voltage from 0 to 2.5 kV
  • variable resistance from 0 to 780 Ohms
  • the electric discharge takes place in a few milliseconds between the two electrodes.
  • the bacterial suspension thus treated is kept in ice.
  • the percentage of lysis after the pulse is determined immediately after collection of the sample, by measuring the optical density at 550 nm.
  • the percentage of lysis is equal to the ratio of the OD value at 550 nm of the bacterial solution after pulse, to the OD value at 550 nm before pulse.
  • two voltage values have been chosen, 450 V and 2.5 kV.
  • the capacitance values were varied from 0 to 25 ⁇ FD at 2.5 kV, and from 0 to 960 ⁇ F at 450 V.
  • the resistance value is fixed at 186 Ohms.
  • the distance between the two electrodes is 2 mm.
  • the percentage of cell lysis increases with the increase in the applied capacity. For example, it can be noted that 50% lysis is obtained with a capacity of 960 ⁇ F and a voltage of 450 V.
  • the lysis efficiency could be improved by the use of a second device (BTX from Gentronics, MedGene Science) allowing to test higher capacitance values, up to 3190 ⁇ F with a voltage equal to 500 V.
  • the tests carried out on this device confirm that cell lysis is all the more effective the higher the capacity, at constant resistance and tension.
  • capacitance values greater than 950 ⁇ F and voltage and resistance values equal to 500 V and 186 Ohms, respectively, 100% of the bacteria S. treated epidermidis are lysed.
  • b) Electric field The influence of the value of the electric field
  • the cell lysis protocol as described above was then carried out at constant voltage (500 V), constant resistance (186 Ohms) and variable capacity (from 0 to 3190 ⁇ F) on a suspension sample of 300 ⁇ l or 800 ⁇ l, in order to to study the influence of the volume of the sample to be treated on the efficiency of cell lysis.
  • the cell lysis obtained under the electrical conditions described is independent of the volume of cell suspension placed between the two electrodes.
  • the lysis method according to the invention can be applied to other cell species.
  • the second protocol described in a) (BTX, MedGene Science) was tested on other cells (Mycobacterium gordonae, Escherichia coli, Listeria monocytogenes, Streptococcus pneumoniae, Bacillus stearothezmophilus, Micrococcus sp., Actinomyces viscosus, Actinomyces naeslundii,
  • Rhodococcus sp. by setting the following electrical parameters as follows: Voltage 500V,
  • Example 2 Analysis of 16S nucleic acids (DNA / RNA) obtained after lysis according to the method of the invention.
  • the bacterial pellet (S. epidermidis - strain A054) is suspended in water at a concentration of 3.3 ⁇ 10 6 cells / ml in the presence or absence of proteinase K at the final concentration of 6 mg / ml (EC 3.4.21.14 Boehringer-Mannheim, ref. 1092766).
  • the protocol is carried out under the conditions determined in Example 1 (voltage: 500 V, resistance: 186 Ohms and capacity: 1500 ⁇ F).
  • the bacterial suspension additionally contains proteinase K
  • the sample is incubated for 15 minutes at 37 ° C. After treatment, the samples are kept in ice.
  • the efficiency of cell lysis is determined as described in Example 1 by measuring the OD at 550 nm. It is found that this efficiency (100%) is not influenced by the presence of proteinase K in the lysis medium. Furthermore, analysis on 0.8% agarose gel of an aliquot of the lysed sample shows that in the absence of proteinase K treatment, the nucleic material does not penetrate the gel and remains in the wells. gel with cell debris. On the other hand, the nucleic acids released in the samples subjected to digestion by proteinase K migrate in the gel according to their size.
  • nucleic acids obtained after lysis, with / without treatment with proteinase K were analyzed with the Vidas device (bioMérieux France) which makes it possible to specifically detect nucleic acids according to the hybridization technique said sandwich, using oligonucleic capture and specific detection probes of the 16S nucleic acids of S. epidermidis ⁇ P 0632269).
  • Oligonucleotides of capture and detection have respectively the sequence 5 '-GACCACCTGTCACTCTGTCCC-3' (SEQ ID NO: 1) and 5'- GGAAGGGGAAAACTCTATCTC-3 '(SEQ ID NO: 2).
  • the detection probe is labeled by coupling with alkaline phosphatase (AKP).
  • Example 3 Amplification of DNA nucleic acids and 16S RNA released by lysis according to the method of one invention.
  • the nucleic acids collected according to example 2 are subjected to an amplification.
  • the lysis conditions are as follows:
  • epidermidis Two specific amplification protocols for S nucleic acids. epidermidis were made from the lysates collected, i.e. a PCR protocol for DNA amplification, a NASBA protocol for the amplification of 16S rRNA.
  • PCR protocol the PCR technique followed is that described by Goodman in PCR strategies, Ed: Innis, Gelford and Sninsky Académie press 1995, pp 17-31. Two amplification primers were used, they have the following sequences:
  • NASBA protocol the NASBA technique followed is that described by Van Der Vliet et al., J. Gen. Microbiol.
  • Amplification signal is detected after specific sandwich hybridization of the amplicons produced on Vidas as described in Example 2, for an initial bacterial concentration equal to or greater than 300 bacteria / 300 ⁇ l.
  • NASBA amplification of the 16S RNA released 5 ⁇ l of lysate are used for each NASBA test.
  • the amplicons produced are detected and quantified on a microplate by hybridization with a capture probe and a specific S detection probe.
  • epidermidis according to the method described by P. Cros et al., Lancet 1992, 240: 870.
  • the detection probe is coupled to "Horse Radish Peroxidase" (HRP).
  • HRP "Horse Radish Peroxidase”

Abstract

The invention concerns a method for isolating a nucleic and/or protein intracellular substance, from a cell sample suspended in a liquid, comprising the following steps: exposing the sample to at least an electric pulse, whereof at least one characteristic is determined for a partial or complete lysis of the intracellular substance; separating from the lysed cell substance a nucleic and/or protein fraction. The invention is characterised in that: a) the duration of the electric pulse, defined by the time interval during which the voltage is not less than 50 % of the maximum voltage, is not less than 200 ms; and b) after separating protein fraction from the nucleic fraction of the lysed cells, the nucleic and/or protein fraction can be directly subjected to at least a treating step.

Description

PROCEDE POUR ISOLER UN MATERIEL INTRACELLULAIRE METHOD FOR ISOLATING INTRACELLULAR MATERIAL
La présente invention concerne un procédé pour isoler un matériel intracellulaire, nucléique et/ou protéique, à partir d'un échantillon cellulaire en suspension dans un liquide, comprenant une étape de lyse cellulaire et une étape de séparation.The present invention relates to a method for isolating intracellular, nucleic and / or protein material, from a cell sample suspended in a liquid, comprising a cell lysis step and a separation step.
Le procédé de l'invention est simple à mettre en oeuvre, est adapté à toute cellule, cellule eucaryote, cellule procaryote, notamment bactérie Gram + ou Gram -, quelle que soit la nature et la résistance de l'enveloppe cellulaire, et permet d'accéder directement au matériel intracellulaire sans qu'une étape supplémentaire de purification ne soit nécessaire.The process of the invention is simple to implement, is suitable for any cell, eukaryotic cell, prokaryotic cell, in particular Gram + or Gram - bacteria, whatever the nature and the resistance of the cell envelope, and makes it possible to '' Direct access to the intracellular material without the need for an additional purification step.
La Demanderesse a découvert, de manière complètement inattendue, que l'exposition d'un échantillon cellulaire à une impulsion électrique, dans des conditions réactionnelles déterminées, conduit à une lyse cellulaire avec un rendement maximal, tout en libérant des constituants intracellulaires sous une forme directement exploitable dans une étape ultérieure de traitement, notamment séparation.The Applicant has discovered, completely unexpectedly, that the exposure of a cell sample to an electric pulse, under determined reaction conditions, leads to cell lysis with maximum yield, while liberating intracellular constituents in a form directly exploitable in a subsequent stage of treatment, in particular separation.
Comme le résume l'article de T. Y. TSONG (dans Biophysical Journal of Biochemical Society (1991) (5(), 297- 308) , on connaît un procédé de traitement électrique d'une suspension de cellules, utilisé dans la technique dite d'électroporation, et caractérisé par l'exposition de la suspension à un champ électrique. Selon cette technique, on provoque la perforation de la membrane cellulaire pour obtenir des pores, au travers desquels les constituants intracellulaires vont sortir, mais par lesquels il est ainsi possible d'introduire diverses substances exogènes. La grande variété des substances que 1 ' on peut incorporer comme par exemple des molécules à activité biologique, pharmaceutique, des acides ou fragments d'acides nucléiques, et notamment plasmides, confère à cette technique un large spectre d'utilisations. Plus précisément cette technique consiste à appliquer un champ électrique d'une intensité supérieure à la force diélectrique de la membrane cellulaire, entraînant une modification de sa conductivité et donc de sa perméabilité. A condition d'opérer dans des conditions sensiblement isotoniques pour qu'une pression osmotique du même ordre existe entre l'intérieur et l'extérieur de la cellule, cette transformation structurale de la membrane est réversible, et lorsque la suspension n'est plus soumise à l'effet du champ électrique, les pores se referment, emprisonnant les substances exogènes qui se sont introduites. A chaque espèce de cellules correspond une valeur optimale du champ électrique. Cette dernière dépend directement de la résistance et de la constitution de la paroi cellulaire. Il faut noter qu'un champ d'intensité trop élevée provoque la formation de pores d'une taille telle qu'ils ne peuvent plus se refermer, et entraîne ainsi la mort de la cellule.As summarized in the article by TY TSONG (in Biophysical Journal of Biochemical Society (1991) (5 (), 297-308), there is a known method of electrical treatment of a suspension of cells, used in the technique known as electroporation, and characterized by the exposure of the suspension to an electric field. According to this technique, the cell membrane is perforated to obtain pores, through which the intracellular constituents will exit, but through which it is thus possible to The introduction of various exogenous substances. The wide variety of substances which can be incorporated, such as, for example, molecules with biological or pharmaceutical activity, acids or fragments of nucleic acids, and in particular plasmids, gives this technique a wide spectrum of uses. More precisely, this technique consists in applying an electric field of an intensity greater than the dielectric force of the cell membrane, resulting in a modification of its conductivity and therefore of its permeability. Provided that it operates under substantially isotonic conditions so that an osmotic pressure of the same order exists between the interior and the exterior of the cell, this structural transformation of the membrane is reversible, and when the suspension is no longer subjected as a result of the electric field, the pores close up, trapping the exogenous substances that have entered. Each species of cell has an optimal value for the electric field. The latter depends directly on the resistance and the constitution of the cell wall. It should be noted that a field of too high intensity causes the formation of pores of such a size that they can no longer close, and thus causes the death of the cell.
K. KINOSITA et al. (Biochimica et Biophysica Acta (1979) 554. 479-497) ont observé que l'exposition d'une suspension isotonique d'érythrocytes à un champ électrique entraîne l'accroissement de la perméabilité membranaire, mais que le flux de soluté entrant à l'intérieur de la cellule par les pores formés dans la membrane, engendre un gonflement de la cellule qui provoque sa lyse. Cependant ce phénomène de lyse après électroporation, résultant d'une surpression à l'intérieur de la cellule a été observé pour les érythrocytes qui possèdent une membrane plasmique assez peu résistante, et ne peut pas être généralisé à tout type de cellules, notamment bactéries.K. KINOSITA et al. (Biochimica and Biophysica Acta (1979) 554. 479-497) observed that the exposure of an isotonic suspension of erythrocytes to an electric field leads to an increase in membrane permeability, but that the flux of solute entering at inside the cell by the pores formed in the membrane, causes swelling of the cell which causes its lysis. However, this lysis phenomenon after electroporation, resulting from an overpressure inside the cell, has been observed for erythrocytes which have a fairly weak plasma membrane, and cannot be generalized to all types of cells, in particular bacteria.
La demande de brevet WO 91/18103 divulgue un procédé pour rendre perméable des membranes cellulaires afin de faire pénétrer des molécules à l'intérieur. Le procédé consiste à émettre deux décharges successives de courte durée de type rectangulaire, la première de 400 à 25000 V/cm, d'une durée de 10 μs à 10 ms et de capacité 40 μF, la seconde de 50 à 1000 V/cm d'une durée de 1 ms à 1 s, de capacité 1800 μF. Les deux impulsion électriques doivent se suivre dans un laps de temps très court, inférieur à 10 s, afin que le taux de mortalité cellulaire ne soit pas trop élevé.Patent application WO 91/18103 discloses a method for making cell membranes permeable in order to make molecules penetrate inside. The method consists in emitting two successive short-duration rectangular type discharges, the first of 400 to 25,000 V / cm, of a duration of 10 μs to 10 ms and of capacity 40 μF, the second from 50 to 1000 V / cm with a duration of 1 ms to 1 s, with a capacity of 1800 μF. The two electrical impulses must follow each other in a very short period of time, less than 10 s, so that the cell mortality rate is not too high.
La demande de brevet WO 88/02777 divulgue une procédé d'extraction de contenu cellulaire d'origine quelconque tout en préservant la structure cellulaire par l'application de plusieurs décharges électriques courtes, d'une durée comprise entre 1 ns et 1 ms, avec un champ électrique variant de 100 à 15000 V/cm.Patent application WO 88/02777 discloses a method of extracting cellular content of any origin while preserving the cellular structure by the application of several short electrical discharges, of a duration between 1 ns and 1 ms, with an electric field varying from 100 to 15000 V / cm.
Le brevet US 5,326,530 divulgue un procédé pour tuer des bactéries présentes dans un produit contaminé. Le procédé consiste à rompre de manière irréversible les membranes des bactéries par application d'impulsion électriques de l'ordre d'au moins quelques centaines à 10000 V/cm pendant une durée extrêmement courte comprise entre 0,2 et 200 μs.US Patent 5,326,530 discloses a method for killing bacteria present in a contaminated product. The process consists in irreversibly breaking the membranes of bacteria by applying electrical impulses of the order of at least a few hundred at 10,000 V / cm for an extremely short period of between 0.2 and 200 μs.
Selon l'invention, on apporte un procédé permettant en un temps très court de lyser toutes les cellules d'une suspension, quelle que soit la concentration en cellules, c'est-à-dire même pour des fortes concentrations, afin d'isoler un matériel intracellulaire nucléique et/ou protéique, que l'on sépare et qui, après séparation, est suceptible d'être directement soumis à une étape de traitement.According to the invention, there is provided a method allowing in a very short time to lyse all the cells from a suspension, whatever the cell concentration, that is to say even for high concentrations, in order to isolate an intracellular nucleic and / or protein material, which is separated and which, after separation, is liable to be directly subjected to a processing step.
Ce procédé pour isoler un matériel intracellulaire nucléique et/ou protéique, à partir d'un échantillon cellulaire en suspension dans un liquide, comprend les étapes de:This process for isolating intracellular nucleic and / or protein material, from a cell sample suspended in a liquid, comprises the steps of:
- on expose l'échantillon à au moins une impulsion électrique, dont au moins une caractéristique est déterminée pour permettre une lyse partielle ou complète des cellules; - on sépare des cellules lysées une fraction nucléique, et/ou une fraction protéique, et est caractérisé en ce que :- The sample is exposed to at least one electrical pulse, at least one characteristic of which is determined to allow partial or complete lysis of the cells; a nucleic fraction and / or a protein fraction are separated from the lysed cells, and is characterized in that:
(a) la durée de l'impulsion électrique, définie par l'intervalle de temps pendant lequel la tension électrique est au moins égale à 50 % de la tension maximum, est au moins égale à 200 ms, et(a) the duration of the electrical pulse, defined by the time interval during which the electrical voltage is at least equal to 50% of the maximum voltage, is at least equal to 200 ms, and
(b) après séparation de la fraction protéique de la fraction nucléique des cellules lysées, la fraction nucléique est susceptible d'être soumise directement à au moins une étape de traitement. Avant d'exposer des variantes du procédé de l'invention, et d'en détailler les caractéristiques et avantages, on définit ci-après certains termes employés dans la présente description et les revendications.(b) after separation of the protein fraction from the nucleic fraction of the lysed cells, the nucleic fraction may be subjected directly to at least one processing step. Before setting out variants of the process of the invention, and detailing its characteristics and advantages, certain terms used in the present description and the claims are defined below.
Par " isolement d'un matériel intracellulaire " selon l'invention, on comprend la séparation, selon une méthode d'isolement spécifique ou aspécifique, de manière qualitative et/ou quantitative.By "isolation of an intracellular material" according to the invention is understood the separation, according to a specific or aspecific isolation method, qualitatively and / or quantitatively.
Selon une variante du procédé de l'invention, ainsi que l'illustration qui en est faite dans l'exemple 2 et 3 qui suivent, le procédé est appliqué à l'isolement de matériel nucléique, mais bien entendu, cette mise en oeuvre particulière n ' introduit aucune limitation à ce matériel. Ainsi, le matériel intracellulaire à isoler peut consister en une fraction protéique. Par " échantillon cellulaire " selon l'invention, on comprend tout échantillon susceptible de contenir des cellules, notamment un échantillon biologique tel que celui obtenu à partir d'un fluide biologique, un échantillon d'origine alimentaire. L'échantillon consiste en tout ou partie d'un échantillon, en particulier il peut consister en un aliquote, une dilution.According to a variant of the method of the invention, as well as the illustration which is made of it in Example 2 and 3 which follow, the method is applied to the isolation of nucleic material, but of course, this particular implementation does not introduce any limitation to this material. Thus, the intracellular material to be isolated can consist of a protein fraction. By "cell sample" according to the invention is understood any sample capable of containing cells, in particular a biological sample such as that obtained from a biological fluid, a sample of food origin. The sample consists of all or part of a sample, in particular it can consist of an aliquot, a dilution.
Par " lyse partielle ou complète des cellules " selon l'invention, on comprend que les membranes et/ou paroi des cellules présentes dans l'échantillon cellulaire sont irréversiblement lysées, de manière à libérer le matériel intacellulaire que l'on veut isoler puis traiter. Par " susceptible d'être soumise directement à une étape de traitement " , on comprend que le matériel intracellulaire isolé peut être, sans étape supplémentaire de purification, soumis à une étape de traitement utile pour détecter et/ou identifier un composant de la fraction du matériel intracellulaire isolé.By "partial or complete lysis of cells" according to the invention, it is understood that the membranes and / or wall of the cells present in the cell sample are irreversibly lysed, so as to release the intacellular material which one wishes to isolate and then treat . By "capable of being subjected directly to a processing step", it is understood that the isolated intracellular material can be, without additional purification step, subjected to a processing step useful for detecting and / or identifying a component of the fraction of the isolated intracellular material.
Selon l'invention, une impulsion électrique se définit comme un apport important d'énergie électrique sur une courte période. Pour l'étape (a), la durée de l'impulsion peut notamment être déterminée par la capacité et/ou la résistance électrique d'un circuit électrique de charge. A titre d'exemple, la capacité a une valeur au moins égale à 500 μF, de préférence au moins égale à 950 μF, et/ou la résistance a une valeur au moins égale à 50 Ohms.According to the invention, an electrical pulse is defined as a significant contribution of electrical energy over a short period. For step (a), the duration of the pulse can in particular be determined by the capacity and / or the electrical resistance of an electrical charging circuit. For example, the capacitance has a value at least equal to 500 μF, preferably at least equal to 950 μF, and / or the resistance has a value at least equal to 50 Ohms.
Une caractéristique de l'impulsion électrique est avantageusement déterminée pour établir dans 1 ' échantillon un champ électrique au moins égal à 2500 V/cm.A characteristic of the electric pulse is advantageously determined to establish in the sample an electric field at least equal to 2500 V / cm.
Les caractéristiques de l'impulsion électrique à appliquer à l'échantillon cellulaire pour provoquer la lyse selon l'invention, peuvent être atteintes au moyen d'un générateur électrique préconisé pour la technique d'électroporation, bien que la gamme des valeurs des caractéristiques selon l'invention se situe en dehors du domaine de celles utilisées dans l'électroporation.The characteristics of the electrical pulse to be applied to the cell sample to cause lysis according to the invention can be achieved by means of an electric generator recommended for the electroporation technique, although the range of values of the characteristics according to the invention lies outside the field of those used in electroporation.
Pour un meilleur rendement de la lyse cellulaire, le liquide dans lequel l'échantillon cellulaire est en suspension est de préférence l'eau.For a better yield of cell lysis, the liquid in which the cell sample is in suspension is preferably water.
Dans une mise en oeuvre particulière du procédé de l'invention, le matériel intracellulaire à isoler est un matériel nucléique, et on sépare le matériel nucléique 'par mise en contact de l'échantillon cellulaire lysé avec une protéase ou un composé libérant des radicaux organiques. La protéase ou ledit réactif peut être introduit au départ dans l'échantillon cellulaire, pendant ou après l'étape (a) de lyse. La protéase est notamment choisie parmi la pronase, les subtilysines, la pepsine, la trypsine, le lysozyme, la chymotrypsine, 1 'α-chymotrypsine et la protéinase K. Avantageusement, on utilise la protéinase K. La concentration de la protéinase K dans l'échantillon est comprise entre 0,5 et 9 mg/ml, de préférence entre 3 à 6 mg/ml, et de préférence encore, la concentration est égale à 6 mg/ml.In a particular implementation of the inventive method, the intracellular material to be isolated is a nucleic acid material, and separating the nucleic material 'by contacting the lysed cell sample with a protease or a compound releasing organic radicals . The protease or said reagent can be introduced initially into the cell sample, during or after step (a) of lysis. The protease is in particular chosen from pronase, subtilysins, pepsin, trypsin, lysozyme, chymotrypsin, 1 'α-chymotrypsin and proteinase K. Advantageously, proteinase K is used. The concentration of proteinase K in the The sample is between 0.5 and 9 mg / ml, preferably between 3 to 6 mg / ml, and more preferably, the concentration is equal to 6 mg / ml.
Un composé libérant des radicaux utile pour séparer le matériel nucléique est un composé qui peut produire sous certaines conditions telles qu'exposition à une source d'énergie lumineuse, thermique, ou sous certaines conditions chimiques, un radical porteur d'au moins un électron libre, très instable et très réactif. Un composé préférentiel est un percomposé, notamment choisi parmi le périodate, le parapériodate, le peroxyde de sodium, le perborate et par exemple le tétrahydrate de perborate de sodium.A radical-releasing compound useful for separating nucleic material is a compound which can produce, under certain conditions such as exposure to a source of light, thermal energy, or under certain chemical conditions, a radical carrying at least one free electron , very unstable and very reactive. A preferred compound is a per-compound, in particular chosen from periodate, paraperiodate, sodium peroxide, perborate and for example sodium perborate tetrahydrate.
Dans un mode de réalisation préféré selon l'invention, l'étape de traitement est une étape de détection d'au moins un composant de la fraction nucléique ou une étape d'amplification d'au moins un composant de la fraction nucléique.In a preferred embodiment according to the invention, the processing step is a step of detecting at least one component of the nucleic fraction or a step of amplifying at least one component of the nucleic fraction.
Dans cette étape du procédé de traitement d'un matériel nucléique, il est souhaitable que l'étape de lyse (a) entraîne au moins une dénaturation partielle, voire une fragmentation, du matériel nucléique à traiter. Mais le procédé de l'invention peut aussi permettre de récupérer un matériel intracellulaire intact. Par intact, on comprend un matériel substantiellement non dénaturé et non fragmenté. A cet effet, on choisira de préférence une impulsion électrique déterminée par une capacité de 500 μF, une résistance de 186 Ohms et une tension électrique de 500 V. La présente invention est ci-après illustrée dans les exemples 1 à 3 suivants, en référence aux figures 1 à 6.In this step of the method for processing a nucleic material, it is desirable that the lysis step (a) leads to at least partial denaturation, or even fragmentation, of the nucleic material to be treated. However, the method of the invention can also make it possible to recover intact intracellular material. By intact is meant material that is substantially undenatured and unfragmented. For this purpose, we will preferably choose an electrical pulse determined by a capacity of 500 μF, a resistance of 186 Ohms and an electrical voltage of 500 V. The present invention is illustrated below in the following examples 1 to 3, with reference to FIGS. 1 to 6.
La Figure 1 représente le pourcentage de lyse cellulaire en fonction de la capacité du condensateur, pour deux valeurs de la tension de 2 , 5 kV et de 0,45 kV respectivement, et une résistance de 186 Ohms.Figure 1 represents the percentage of cell lysis as a function of the capacitance of the capacitor, for two values of the voltage of 2.5 kV and 0.45 kV respectively, and a resistance of 186 Ohms.
La Figure 2 représente le pourcentage de lyse cellulaire en fonction de la capacité du condensateur, pour une tension de 500 V et une résistance de 186 Ohms.Figure 2 represents the percentage of cell lysis as a function of the capacitance of the capacitor, for a voltage of 500 V and a resistance of 186 Ohms.
La Figure 3 représente le pourcentage de lyse cellulaire en fonction de la capacité du condensateur, pour deux valeurs de la distance entre les électrodes respectivement, pour une tension de 500 V et une résistance de 186 Ohms.Figure 3 shows the percentage of cell lysis as a function of the capacitance of the capacitor, for two values of the distance between the electrodes respectively, for a voltage of 500 V and a resistance of 186 Ohms.
La Figure 4 représente le pourcentage de lyse cellulaire en fonction de la résistance du condensateur, pour trois valeurs de la capacité respectivement, et pour une tension de 500 V. La Figure 5 représente le pourcentage de lyse cellulaire en fonction de la capacité du condensateur, pour deux valeurs du volume de la suspension cellulaire respectivement, pour une tension de 500 V et une résistance de 186 Ohms. La Figure 6 représente le pourcentage de détection des acides nucléiques en fonction de l'impulsion électrique, et plus particulièrement de la capacité du condensateur produisant l'impulsion, pour une tension de 500 V et une résistance de 186 Ohms. Exemple 1 : Efficacité du procédé de l'invention sur la lyse de bactériesFIG. 4 represents the percentage of cell lysis as a function of the resistance of the capacitor, for three values of the capacity respectively, and for a voltage of 500 V. FIG. 5 represents the percentage of cell lysis as a function of the capacity of the capacitor, for two values of the volume of the cell suspension respectively, for a voltage of 500 V and a resistance of 186 Ohms. FIG. 6 represents the percentage of detection of nucleic acids as a function of the electrical pulse, and more particularly of the capacity of the capacitor producing the pulse, for a voltage of 500 V and a resistance of 186 Ohms. Example 1 Effectiveness of the Process of the Invention on the Lysis of Bacteria
1) Protocole général1) General protocol
Le protocole suivant constitue le mode opératoire général pour mettre en oeuvre le procédé de 1 ' invention. Des bactéries à paroi Gram + Staphylococcus epidermidis (souche A054) cultivées en milieu liquide BBC (Bouillon Coeur Cervelle) sont centrifugées à 2500 tours/min pendant 10 minutes, avant d'être resuspendues dans de l'eau à la concentration 3,3.10^ cellules/ml. 300 μl de la suspension sont déposés dans une cuve d' électroporation caractérisée par une distance entre les deux électrodes de 2 mm ou 4 mm. La cuve est placée sur un circuit électrique dont les paramètres électriques sont choisis comme suit :The following protocol constitutes the general procedure for implementing the method of the invention. Gram-walled bacteria Staphylococcus epidermidis (strain A054) grown in BBC liquid medium (Brain Heart Brain) are centrifuged at 2500 rpm for 10 minutes, before being resuspended in water at a concentration of 3.3 × 10 ^ cells / ml. 300 μl of the suspension are placed in an electroporation tank characterized by a distance between the two electrodes of 2 mm or 4 mm. The tank is placed on an electrical circuit whose electrical parameters are chosen as follows:
- tension variable de 0 à 2,5 kV, - résistance variable de 0 à 780 Ohms,- variable voltage from 0 to 2.5 kV, - variable resistance from 0 to 780 Ohms,
- capacité variable de 25 à 3190 μF.- variable capacity from 25 to 3190 μF.
Après lancement de l'impulsion électrique, la décharge électrique se réalise en quelques millisecondes entre les deux électrodes. La suspension bactérienne ainsi traitée est conservée dans la glace.After launching the electric pulse, the electric discharge takes place in a few milliseconds between the two electrodes. The bacterial suspension thus treated is kept in ice.
Le pourcentage de lyse après l'impulsion est déterminé immédiatement après recueil de l'échantillon, par mesure de la densité optique à 550 nm. Le pourcentage de lyse est égal au rapport de la valeur de DO à 550 nm de la solution bactérienne après impulsion, à la valeur de DO à 550 nm avant impulsion.The percentage of lysis after the pulse is determined immediately after collection of the sample, by measuring the optical density at 550 nm. The percentage of lysis is equal to the ratio of the OD value at 550 nm of the bacterial solution after pulse, to the OD value at 550 nm before pulse.
2 ) Influence de différents paramètres, notamment électriques sur l'efficacité de la lyse L'influence de la capacité, de la résistance du condensateur, du champ électrique et du volume de la suspension a été étudiée, a) Capacité Dans un premier temps, on a utilisé l'appareil Gen Puiser I de bioRad (n° 165-2098 version 8-90).2) Influence of various parameters, in particular electrical on the efficiency of the lysis The influence of the capacity, the resistance of the capacitor, the electric field and the volume of the suspension was studied, a) Capacity Initially, we used the Bio Puis Rad Gen I device (n ° 165-2098 version 8-90).
Selon les consignes d'utilisation de l'appareil, deux valeurs de tension ont été choisies, soit 450 V et 2,5 kV. On a fait varier les valeurs de capacité de 0 à 25 μFD sous 2,5 kV, et de 0 à 960 μF sous 450 V. La valeur de la résistance est fixée à 186 Ohms. La distance entre les deux électrodes est de 2 mm. Comme 1 ' indiquent les résultats apparaissant à la Figure 1, on constate que pour une tension déterminée, le pourcentage de lyse cellulaire augmente avec l'élévation de la capacité appliquée. Par exemple, on peut noter que 50 % de lyse sont obtenus avec une capacité de 960 μF et une tension de 450 V.According to the operating instructions for the device, two voltage values have been chosen, 450 V and 2.5 kV. The capacitance values were varied from 0 to 25 μFD at 2.5 kV, and from 0 to 960 μF at 450 V. The resistance value is fixed at 186 Ohms. The distance between the two electrodes is 2 mm. As indicated by the results appearing in FIG. 1, it can be seen that for a given voltage, the percentage of cell lysis increases with the increase in the applied capacity. For example, it can be noted that 50% lysis is obtained with a capacity of 960 μF and a voltage of 450 V.
Dans un second temps, l'efficacité de lyse a pu être améliorée par l'utilisation d'un second appareil (BTX de Gentronics, MedGene Science) permettant de tester des valeurs de capacité supérieures, pouvant atteindre 3190 μF avec une tension égale à 500 V. Les tests réalisés sur cet appareil dont les résultats apparaissent à la Figure 2, confirment que la lyse cellulaire est d'autant plus efficace que la capacité est élevée, à résistance et tension constantes. Ainsi, pour des valeurs de capacité supérieures à 950 μF, et des valeurs de tension et de résistance égales à 500 V et 186 Ohms, respectivement, 100 % des bactéries S . epidermidis traitées sont lysées. b) Champ électrique L'influence de la valeur du champ électriqueIn a second step, the lysis efficiency could be improved by the use of a second device (BTX from Gentronics, MedGene Science) allowing to test higher capacitance values, up to 3190 μF with a voltage equal to 500 V. The tests carried out on this device, the results of which appear in FIG. 2, confirm that cell lysis is all the more effective the higher the capacity, at constant resistance and tension. Thus, for capacitance values greater than 950 μF, and voltage and resistance values equal to 500 V and 186 Ohms, respectively, 100% of the bacteria S. treated epidermidis are lysed. b) Electric field The influence of the value of the electric field
(E = V/d) a ensuite été analysée pour des valeurs de tension (V) , de capacité et de résistance constantes et en faisant varier la distance (d) entre les électrodes de la cuve d'électroporation, L'appareil utilisé est le BTX de Gentronics.(E = V / d) was then analyzed for constant voltage (V), capacity and resistance values and by varying the distance (d) between the electrodes of the electroporation tank, The device used is the BTX from Gentronics.
A 500 V, lorsque la distance est multipliée par deux, le champ électrique appliqué en tout point de la solution est divisé par un facteur deux. On constate dans ces conditions que l'efficacité de la lyse est diminuée, comme montré sur la Figure 3. On constate par ailleurs dans ce cas, qu'il est nécessaire d'appliquer une capacité de 500 μF pour obtenir au moins 90 % de lyse cellulaire. c) RésistanceAt 500 V, when the distance is multiplied by two, the electric field applied at any point in the solution is divided by a factor of two. It is found under these conditions that the efficiency of the lysis is reduced, as shown in Figure 3. We also note in this case, that it is necessary to apply a capacity of 500 μF to obtain at least 90% of cell lysis. c) Resistance
L'efficacité de la lyse cellulaire a été analysée dans des conditions de tension constante de 500 V, et pour des valeurs variables de capacité (de 500 μF à 3190 μF) et de résistance (de 0 à 780 Ohms). Comme l'indiquent les résultats représentés sur la Figure 4, l'efficacité de la lyse cellulaire augmente avec la valeur de la résistance pour des valeurs constantes de tension et de capacité. d) Volume de la suspension cellulaireThe efficiency of cell lysis was analyzed under constant voltage conditions of 500 V, and for variable capacitance values (from 500 μF to 3190 μF) and resistance (from 0 to 780 Ohms). As indicated by the results shown in Figure 4, the efficiency of cell lysis increases with the value of resistance for constant values of voltage and capacity. d) Volume of the cell suspension
Le protocole de lyse cellulaire tel que décrit précédemment a ensuite été conduit à tension constante (500 V), résistance constante (186 Ohms) et capacité variable (de 0 à 3190 μF) sur un échantillon de suspension de 300 μl ou 800 μl, afin d'étudier l'influence du volume de l'échantillon à traiter sur l'efficacité de la lyse cellulaire.The cell lysis protocol as described above was then carried out at constant voltage (500 V), constant resistance (186 Ohms) and variable capacity (from 0 to 3190 μF) on a suspension sample of 300 μl or 800 μl, in order to to study the influence of the volume of the sample to be treated on the efficiency of cell lysis.
Comme l'indique la figure 5, la lyse cellulaire obtenue dans les conditions électriques décrites est indépendante du volume de suspension cellulaire placé entre les deux électrodes.As indicated in FIG. 5, the cell lysis obtained under the electrical conditions described is independent of the volume of cell suspension placed between the two electrodes.
3) Efficacité de la lyse selon le procédé de l'invention sur d'autres espèces cellulaires Le procédé de lyse selon l'invention peut être appliqué à d'autres espèces cellulaires. Pour cela, le second protocole décrit en a) (BTX, MedGene Science) a été testé sur d'autres cellules (Mycobacterium gordonae, Escherichia coli, Listeria monocytogenes , Streptococcus pneumoniae, Bacillus stearothezmophilus , Micrococcus sp . , Actinomyces viscosus, Actinomyces naeslundii,3) Efficiency of the lysis according to the method of the invention on other cell species The lysis method according to the invention can be applied to other cell species. For this, the second protocol described in a) (BTX, MedGene Science) was tested on other cells (Mycobacterium gordonae, Escherichia coli, Listeria monocytogenes, Streptococcus pneumoniae, Bacillus stearothezmophilus, Micrococcus sp., Actinomyces viscosus, Actinomyces naeslundii,
Stomatococcus mucilaginosus , Nocardia asteroides ,Stomatococcus mucilaginosus, Nocardia asteroides,
Rhodococcus sp . ) en fixant les paramètres électriques suivants comme suit : Tension 500V,Rhodococcus sp. ) by setting the following electrical parameters as follows: Voltage 500V,
Capacité 1500 μF et Résistance 186 Ohms.Capacity 1500 μF and Resistance 186 Ohms.
Les résultats obtenus indiquent que le pourcentage de lyse cellulaire pour chacun des cas analysés est compris entre 80 et 100 %. Exemple 2 : Analyses des acides nucléiques (ADN/ARN) 16S obtenus après lyse selon le procédé de 1 ' invention.The results obtained indicate that the percentage of cell lysis for each of the cases analyzed is between 80 and 100%. Example 2: Analysis of 16S nucleic acids (DNA / RNA) obtained after lysis according to the method of the invention.
Après l'étape de centrifugation (voir exemple 1), le culot bactérien (S. epidermidis - souche A054) est mis en suspension dans de l'eau à la concentration de 3,3.10^ cellules/ml en présence ou en absence de protéinase K à la concentration finale de 6 mg/ml (E.C. 3.4.21.14 Boehringer-Mannheim, réf. 1092766). Le protocole est conduit dans les conditions déterminées à l'exemple 1 (tension : 500 V, résistance : 186 Ohms et capacité : 1500 μF). Lorsque la suspension bactérienne renferme en outre de la protéinase K, après lyse cellulaire l'échantillon est incubé 15 minutes à 37°C. Après traitement, les échantillons sont conservés dans la glace.After the centrifugation step (see example 1), the bacterial pellet (S. epidermidis - strain A054) is suspended in water at a concentration of 3.3 × 10 6 cells / ml in the presence or absence of proteinase K at the final concentration of 6 mg / ml (EC 3.4.21.14 Boehringer-Mannheim, ref. 1092766). The protocol is carried out under the conditions determined in Example 1 (voltage: 500 V, resistance: 186 Ohms and capacity: 1500 μF). When the bacterial suspension additionally contains proteinase K, after cell lysis the sample is incubated for 15 minutes at 37 ° C. After treatment, the samples are kept in ice.
L'efficacité de la lyse cellulaire est déterminée comme décrit à l'exemple 1 par mesure de la DO à 550 nm. On constate que cette efficacité (100 %) n'est pas influencée par la présence de la protéinase K dans le milieu de lyse. Par ailleurs, l'analyse sur gel d'agarose 0,8 % d'un aliquote de l'échantillon lysé montre qu'en absence de traitement à la protéinase K, le matériel nucléique ne pénètre pas dans le gel et demeure dans les puits du gel avec les débris cellulaires. Par contre, les acides nucléiques libérés dans les échantillons soumis à la digestion par la protéinase K migrent dans le gel en fonction de leur taille.The efficiency of cell lysis is determined as described in Example 1 by measuring the OD at 550 nm. It is found that this efficiency (100%) is not influenced by the presence of proteinase K in the lysis medium. Furthermore, analysis on 0.8% agarose gel of an aliquot of the lysed sample shows that in the absence of proteinase K treatment, the nucleic material does not penetrate the gel and remains in the wells. gel with cell debris. On the other hand, the nucleic acids released in the samples subjected to digestion by proteinase K migrate in the gel according to their size.
Dans une seconde série d'expérience, les acides nucléiques obtenus après lyse, avec/sans traitement à la protéinase K, ont été analysés avec l'appareil Vidas (bioMérieux France) qui permet de détecter spécifiquement des acides nucléiques selon la technique d'hybridation dite sandwich, en utilisant des sondes oligonucléiques de capture et de détection spécifiques des acides nucléiques 16S de S . epidermidis ΕP 0632269). Les oligonucléotides de capture et de détection ont respectivement pour séquence 5 ' -GACCACCTGTCACTCTGTCCC-3 ' ( SEQ ID NO: 1) et 5'- GGAAGGGGAAAACTCTATCTC-3 ' (SEQ ID NO: 2). La sonde de détection est marquée par couplage avec la phosphatase alcaline (AKP) .In a second series of experiments, the nucleic acids obtained after lysis, with / without treatment with proteinase K, were analyzed with the Vidas device (bioMérieux France) which makes it possible to specifically detect nucleic acids according to the hybridization technique said sandwich, using oligonucleic capture and specific detection probes of the 16S nucleic acids of S. epidermidis ΕP 0632269). Oligonucleotides of capture and detection have respectively the sequence 5 '-GACCACCTGTCACTCTGTCCC-3' (SEQ ID NO: 1) and 5'- GGAAGGGGAAAACTCTATCTC-3 '(SEQ ID NO: 2). The detection probe is labeled by coupling with alkaline phosphatase (AKP).
Cette analyse montre qu ' en 1 ' absence de traitement par la protéinase K, les acides nucléiques ADN/ARN libérés après électroporation ne sont pas détectables par la technique mise oeuvre. Au contraire, le traitement par la protéinase K permet la détection spécifique desdits acides nucléiques, libérés lors de la lyse cellulaire.This analysis shows that in the absence of treatment with proteinase K, the DNA / RNA nucleic acids released after electroporation are not detectable by the technique used. On the contrary, treatment with proteinase K allows specific detection of said nucleic acids, released during cell lysis.
L'influence du paramètre électrique relatif à la capacité sur la détection spécifique des acides nucléiques 16S de S . epidermidis a été analysée. Les résultats apparaissent sur la figure 6. La détection des acides nucléiques est exprimée en RFU, c'est-à-dire en unité de fluorescence relative. Ces résultats confirment l'influence de la capacité dans la libération des acides nucléiques contenus dans les cellules lors de la lyse réalisée conformément à l'invention.The influence of the electrical parameter relating to capacity on the specific detection of 16S nucleic acids from S. epidermidis has been analyzed. The results appear in FIG. 6. The detection of nucleic acids is expressed in RFU, that is to say in relative fluorescence unit. These results confirm the influence of the capacity in the release of the nucleic acids contained in the cells during the lysis carried out in accordance with the invention.
Exemple 3 : Amplification des acides nucléiques ADN et ARN 16S libérés par lyse selon le procédé de 1 ' invention. Les acides nucléiques recueillis selon l'exemple 2 sont soumis à une amplification. Les conditions de lyse sont les suivantes :Example 3: Amplification of DNA nucleic acids and 16S RNA released by lysis according to the method of one invention. The nucleic acids collected according to example 2 are subjected to an amplification. The lysis conditions are as follows:
Appareil BTX Gentronics, Tension 500 V, Résistance 186 Ohms,BTX Gentronics device, Voltage 500 V, Resistance 186 Ohms,
Capacité 1500 μFD, une impulsion électrique.Capacity 1500 μFD, one electrical pulse.
Deux protocoles d'amplification spécifiques des acides nucléiques de S . epidermidis ont été réalisés à partir des lysats recueillis, soit un protocole PCR pour l'amplification de l'ADN, soit un protocole NASBA pour l'amplification de l'ARNr 16S.Two specific amplification protocols for S nucleic acids. epidermidis were made from the lysates collected, i.e. a PCR protocol for DNA amplification, a NASBA protocol for the amplification of 16S rRNA.
Protocole PCR : la technique de PCR suivie est celle décrite par Goodman dans PCR stratégies, Ed: Innis, Gelford et Sninsky Académie press 1995, pp 17-31. Deux amorces d'amplification ont été utilisées, elles présentent les séquences suivantes :PCR protocol: the PCR technique followed is that described by Goodman in PCR strategies, Ed: Innis, Gelford and Sninsky Académie press 1995, pp 17-31. Two amplification primers were used, they have the following sequences:
Amorce 1 5' ATCTTGACATCCTCTGACC 3 ' SEQ ID NO: 3 Amorce 2 5' TCGACGGCTAGCTCCAAAT 3' SEQ ID NO: 4 Les cycles de température suivants ont été utilisés :Primer 1 5 'ATCTTGACATCCTCTGACC 3' SEQ ID NO: 3 Primer 2 5 'TCGACGGCTAGCTCCAAAT 3' SEQ ID NO: 4 The following temperature cycles were used:
1 fois 3 minutes 94 °C1 time 3 minutes 94 ° C
2 minutes 65°C2 minutes 65 ° C
35 fois 1 minutes 72°C 1 minutes 94 °C35 times 1 minute 72 ° C 1 minute 94 ° C
2 minutes 65°C 1 fois 5 minutes 72 °C2 minutes 65 ° C 1 time 5 minutes 72 ° C
Protocole NASBA : la technique de NASBA suivie est celle décrite par Van Der Vliet et al., J. Gen. Microbiol.NASBA protocol: the NASBA technique followed is that described by Van Der Vliet et al., J. Gen. Microbiol.
1993, 139 : 2423. Deux amorces d'amplification ont été utilisées, elles présentent les séquences suivantes :1993, 139: 2423. Two amplification primers were used, they present the following sequences:
Amorce 1 :Primer 1:
5' GGTTTGTCACCGGCAGTCAACTTAGA 3' SEQ ID NO: 5 Amorce 2 :5 'GGTTTGTCACCGGCAGTCAACTTAGA 3' SEQ ID NO: 5 Primer 2:
5' TCGAAGCAACGCGAAGAACCTTACCA 3' SEQ ID NO: 65 'TCGAAGCAACGCGAAGAACCTTACCA 3' SEQ ID NO: 6
1) Amplification PCR de l'ADN libéré1) PCR amplification of the released DNA
10 μl de lysat sont utilisés pour chaque essai PCR. Les amplicons produits sont analysés sur gel d'agarose 0,8 % et sur Vidas selon le protocole décrit à l'exemple 2. En l'absence de protéinase K, on constate que l'ADN libéré après lyse n'est pas amplifié. Par contre, on constate que l'ADN libéré après lyse en présence de 0,3 μg/ml final de protéinase K et incubation 15 minutes à10 μl of lysate are used for each PCR test. The amplicons produced are analyzed on 0.8% agarose gel and on Vidas according to the protocol described in Example 2. In the absence of proteinase K, it is found that the DNA released after lysis is not amplified. On the other hand, it is found that the DNA released after lysis in the presence of 0.3 μg / ml final proteinase K and incubation for 15 minutes at
37 °C est amplifié. Un signal d'amplification est détecté après hybridation sandwich spécifique des amplicons produits sur Vidas comme décrit dans l'exemple 2, pour une concentration bactérienne initiale égale ou supérieure à 300 bactéries/300 μl.37 ° C is amplified. Amplification signal is detected after specific sandwich hybridization of the amplicons produced on Vidas as described in Example 2, for an initial bacterial concentration equal to or greater than 300 bacteria / 300 μl.
2) Amplification NASBA de l'ARN 16S libéré 5 μl de lysat sont utilisés pour chaque essai NASBA. Les amplicons produits sont détectés et quantifiés sur microplaque par hybridation avec une sonde de capture et une sonde de détection spécifique de S . epidermidis , suivant la méthode décrite par P. Cros et al., Lancet 1992, 240: 870. La sonde de détection est couplée à la "Horse Radish Peroxidase" (HRP). Les deux sondes présentent les séquences suivantes : Sonde de capture :2) NASBA amplification of the 16S RNA released 5 μl of lysate are used for each NASBA test. The amplicons produced are detected and quantified on a microplate by hybridization with a capture probe and a specific S detection probe. epidermidis, according to the method described by P. Cros et al., Lancet 1992, 240: 870. The detection probe is coupled to "Horse Radish Peroxidase" (HRP). The two probes have the following sequences: Capture probe:
5' GATAGAGTTTTCCCCTTC 3" SEQ ID NO: 75 'GATAGAGTTTTCCCCTTC 3 "SEQ ID NO: 7
Sonde de détection :Detection probe:
5' GACATCCTCTGACCCCTC 3' SEQ ID NO: 85 'GACATCCTCTGACCCCTC 3' SEQ ID NO: 8
En l'absence de protéinase K, on constate que l'ARNr 16S libéré après lyse, suivie ou non d'une incubation de 15 minutes à 37°, n'est pas amplifié. Par contre, on constate que l'ARNr 16S libéré après lyse en présence de 0,3 μg/ml final de protéinase K et incubation de 15 minutes à 37 °C est amplifié. Un signal d'amplification est détecté après hybridation spécifique des amplicons produits sur microplaque, comme décrit ci- dessus, pour une concentration bactérienne initiale égale ou supérieure à 60 bactéries/ml. In the absence of proteinase K, it is found that the 16S rRNA released after lysis, whether or not followed by an incubation of 15 minutes at 37 °, is not amplified. On the other hand, it is found that the 16S rRNA released after lysis in the presence of 0.3 μg / ml final proteinase K and incubation for 15 minutes at 37 ° C is amplified. An amplification signal is detected after specific hybridization of the amplicons produced on a microplate, as described above, for an initial bacterial concentration equal to or greater than 60 bacteria / ml.

Claims

REVENDICATIONS
1. Procédé pour isoler un matériel intracellulaire nucléique et/ou protéique, à partir d'un échantillon cellulaire en suspension dans un liquide, comprenant les étapes de :1. A method for isolating an intracellular nucleic and / or protein material, from a cellular sample suspended in a liquid, comprising the steps of:
- on expose l'échantillon à au moins une impulsion électrique, dont au moins une caractéristique est déterminée pour permettre une lyse partielle ou complète des cellules; - on sépare des cellules lysées une fraction nucléique, e /ou une fraction protéique, caractérisé en ce que :- The sample is exposed to at least one electrical pulse, at least one characteristic of which is determined to allow partial or complete lysis of the cells; - A nucleic fraction, e / or a protein fraction, is separated from the lysed cells, characterized in that:
(a) la durée de l'impulsion électrique, définie par l'intervalle de temps pendant lequel la tension électrique est au moins égale à 50 % de la tension maximum, est au moins égale à 200 ms, et(a) the duration of the electrical pulse, defined by the time interval during which the electrical voltage is at least equal to 50% of the maximum voltage, is at least equal to 200 ms, and
(b) après séparation de la fraction protéique de la fraction nucléique des cellules lysées, la fraction nucléique et/ou protéique est susceptible d'être soumise directement à au moins une étape de traitement.(b) after separation of the protein fraction from the nucleic fraction of the lysed cells, the nucleic and / or protein fraction is capable of being subjected directly to at least one processing step.
2. Procédé selon la revendication 1, caractérisé en ce que le matériel intracellulaire isolé est une fraction nucléique.2. Method according to claim 1, characterized in that the isolated intracellular material is a nucleic fraction.
3. Procédé selon les revendications 1 et 2, caractérisé en ce que la lyse complète des cellules entraîne au moins une dénaturation partielle, voire une fragmentation, du matériel nucléique à traiter.3. Method according to claims 1 and 2, characterized in that the complete lysis of the cells leads to at least partial denaturation, or even fragmentation, of the nucleic material to be treated.
4. Procédé selon la revendication 1, caractérisé en ce qu'au moins une caractéristique de l'impulsion électrique est déterminée pour établir dans l'échantillon un champ électrique au moins égal à 2500 V/cm.4. Method according to claim 1, characterized in that at least one characteristic of the electric pulse is determined to establish in the sample an electric field at least equal to 2500 V / cm.
5. Procédé selon la revendication 1, caractérisé en ce la durée de 1 ' impulsion électrique est déterminée par une capacité de 500 μF et une résistance électrique de 186 Ohms, pour une tension électrique de 500 V. 5. Method according to claim 1, characterized in that the duration of one electrical pulse is determined by a capacity of 500 μF and an electrical resistance of 186 Ohms, for an electrical voltage of 500 V.
6. Procédé selon la revendication 1, caractérisé en ce que le liquide dans lequel l'échantillon cellulaire est en suspension est l'eau.6. Method according to claim 1, characterized in that the liquid in which the cell sample is in suspension is water.
7. Procédé selon les revendications 1 et 2, caractérisé en ce qu'on sépare le matériel nucléique par mise en contact de l'échantillon cellulaire lysé avec une protéase ou un composé libérant des radicaux organiques .7. Method according to claims 1 and 2, characterized in that the nucleic material is separated by bringing the lysed cell sample into contact with a protease or a compound releasing organic radicals.
8. Procédé selon la revendication 7, caractérisé en ce que la protéase ou le composé est introduit au départ dans l'échantillon cellulaire.8. Method according to claim 7, characterized in that the protease or the compound is initially introduced into the cell sample.
9. Procédé selon la revendication 8, caractérisé en ce que la séparation du matériel nucléique est effectuée avec une protéase, choisie parmi la pronase, les subtilysines, la pepsine, la trypsine, le lysozyme, la chymotrypsine, 1 'α-chymotrypsine et la protéinase K.9. Method according to claim 8, characterized in that the separation of the nucleic material is carried out with a protease, chosen from pronase, subtilysins, pepsin, trypsin, lysozyme, chymotrypsin, 1 'α-chymotrypsin and proteinase K.
10. Procédé selon la revendication 9, caractérisé en ce que la protéase est la protéinase K.10. Method according to claim 9, characterized in that the protease is proteinase K.
11. Procédé selon la revendication 10, caractérisé en ce que la concentration de la protéinase K dans l'échantillon est comprise entre 0,5 et 9 mg/ml, de préférence entre 3 à 6 mg/ml, et de préférence encore la concentration est égale à 6 mg/ml.11. Method according to claim 10, characterized in that the concentration of proteinase K in the sample is between 0.5 and 9 mg / ml, preferably between 3 to 6 mg / ml, and more preferably the concentration is equal to 6 mg / ml.
12. Procédé selon la revendication 7, caractérisé en ce que le composé est un percomposé, notamment choisi parmi le périodate, le parapériodate, le peroxyde de sodium, le perborate et par exemple le tétrahydrate de perborate de sodium.12. A method according to claim 7, characterized in that the compound is a per-compound, in particular chosen from periodate, paraperiodate, sodium peroxide, perborate and for example sodium perborate tetrahydrate.
13. Procédé selon l'une quelconque des revendications 1 à 12, caractérisé en ce que l'étape de traitement est une étape de détection d'au moins un composant de la fraction nucléique.13. Method according to any one of claims 1 to 12, characterized in that the processing step is a step of detecting at least one component of the nucleic fraction.
14. Procédé selon 1 ' une quelconque des revendications 1 à 12, caractérisé en ce que l'étape de traitement est une étape d'amplification d'au moins un composant de la fraction nucléique. 14. Method according to any one of claims 1 to 12, characterized in that the processing step is a step of amplification of at least one component of the nucleic fraction.
PCT/FR1998/001098 1997-05-29 1998-05-29 Method for isolating an intracellular substance WO1998054306A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU80242/98A AU8024298A (en) 1997-05-29 1998-05-29 Method for isolating an intracellular substance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706835A FR2763957B1 (en) 1997-05-29 1997-05-29 METHOD FOR ISOLATING INTRACELLULAR MATERIAL AND METHOD FOR TREATING NUCLEIC MATERIAL
FR97/06835 1997-05-29

Publications (1)

Publication Number Publication Date
WO1998054306A1 true WO1998054306A1 (en) 1998-12-03

Family

ID=9507548

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1998/001098 WO1998054306A1 (en) 1997-05-29 1998-05-29 Method for isolating an intracellular substance

Country Status (3)

Country Link
AU (1) AU8024298A (en)
FR (1) FR2763957B1 (en)
WO (1) WO1998054306A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000049173A2 (en) * 1999-02-15 2000-08-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Method and sample support system for separating and processing substances in situ
EP1199353A1 (en) * 2000-10-10 2002-04-24 Bestfoods Process for producing yeast extracts
FR2815640A1 (en) * 2000-10-19 2002-04-26 Centre Nat Rech Scient Releasing proteins from cells in flowing medium, useful e.g. for preparing enzymes, by applying electrical pulses to cause irreversible permeabilization but not lysis

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10004147A1 (en) * 2000-01-31 2001-08-09 Gsf Forschungszentrum Umwelt Oligonucleotides for the amplification and qualitative and quantitative detection of bacterial 16S rRNA useful to determine bacterial contamination of foodstuffs, waters, and in clinical microbiology

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002777A1 (en) * 1986-10-10 1988-04-21 Electropore Inc. Process for extracting cell contents
US4838154A (en) * 1985-05-31 1989-06-13 Maxwell Laboratories, Inc. Apparatus for extending the shelf life of fluid food products
DE3827414A1 (en) * 1988-02-01 1989-08-10 Herfurth Gmbh Arrangement for treating and/or breaking down biological cell structures
WO1991018103A1 (en) * 1990-05-16 1991-11-28 Scientific Equipment Design & Development S.C. Method and device for making living cells permeable
US5098843A (en) * 1987-06-04 1992-03-24 Calvin Noel M Apparatus for the high efficiency transformation of living cells
US5326530A (en) * 1991-01-22 1994-07-05 Iit Research Institute Energy-efficient electromagnetic elimination of noxious biological organisms
US5346999A (en) * 1985-01-18 1994-09-13 Applied Biosystems, Inc. Method of nucleic acid extraction
WO1994026867A1 (en) * 1993-05-06 1994-11-24 Abbott Laboratories Direct lysis buffer and the detection of hiv-1 plasma viremia
EP0765843A1 (en) * 1995-09-28 1997-04-02 Remodeling 21 Co., Ltd. Deactivating or destroying microorganisms by an electrical charge

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346999A (en) * 1985-01-18 1994-09-13 Applied Biosystems, Inc. Method of nucleic acid extraction
US4838154A (en) * 1985-05-31 1989-06-13 Maxwell Laboratories, Inc. Apparatus for extending the shelf life of fluid food products
WO1988002777A1 (en) * 1986-10-10 1988-04-21 Electropore Inc. Process for extracting cell contents
US5098843A (en) * 1987-06-04 1992-03-24 Calvin Noel M Apparatus for the high efficiency transformation of living cells
DE3827414A1 (en) * 1988-02-01 1989-08-10 Herfurth Gmbh Arrangement for treating and/or breaking down biological cell structures
WO1991018103A1 (en) * 1990-05-16 1991-11-28 Scientific Equipment Design & Development S.C. Method and device for making living cells permeable
US5326530A (en) * 1991-01-22 1994-07-05 Iit Research Institute Energy-efficient electromagnetic elimination of noxious biological organisms
WO1994026867A1 (en) * 1993-05-06 1994-11-24 Abbott Laboratories Direct lysis buffer and the detection of hiv-1 plasma viremia
EP0765843A1 (en) * 1995-09-28 1997-04-02 Remodeling 21 Co., Ltd. Deactivating or destroying microorganisms by an electrical charge

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. H. SALE ET AL.: "Effects of high electric fields on micro-organisms I. Killing of bacteria and yeasts", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 148, - 1967, NL, pages 781 - 788, XP002057602 *
W. A. HAMILTON ET AL.: "Effects of high electric fields on micro-organisms II. Mechanism of action of the lethal effect.", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 148, - 1969, NL, pages 789 - 800, XP002057603 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000049173A2 (en) * 1999-02-15 2000-08-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Method and sample support system for separating and processing substances in situ
WO2000049173A3 (en) * 1999-02-15 2002-01-31 Fraunhofer Ges Forschung Method and sample support system for separating and processing substances in situ
US6699698B1 (en) 1999-02-15 2004-03-02 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Method and sample mount system for the in situ separation and enrichment of substances
EP1199353A1 (en) * 2000-10-10 2002-04-24 Bestfoods Process for producing yeast extracts
FR2815640A1 (en) * 2000-10-19 2002-04-26 Centre Nat Rech Scient Releasing proteins from cells in flowing medium, useful e.g. for preparing enzymes, by applying electrical pulses to cause irreversible permeabilization but not lysis
WO2002033065A3 (en) * 2000-10-19 2003-05-30 Centre Nat Rech Scient Method for producing proteins by electroporation

Also Published As

Publication number Publication date
FR2763957B1 (en) 2001-09-14
FR2763957A1 (en) 1998-12-04
AU8024298A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
EP1559784A3 (en) Rapid extraction of RNA from cells and tissues
EP1017784B1 (en) Process for the lysis of microorganisms
FR2926560A1 (en) PROCESS FOR EXTRACTING AND PURIFYING NUCLEIC ACIDS ON MEMBRANE
WO2000026405A1 (en) Apparatus and method for lysing bacterial spores to facilitate their identification
FR2885140A1 (en) METHOD FOR DETECTING AND CHARACTERIZING MICROORGARISTS ON A MEMBRANE
WO1998054306A1 (en) Method for isolating an intracellular substance
White et al. Flash detection/identification of pathogens, bacterial spores and bioterrorism agent biomarkers from clinical and environmental matrices
FR2636075A1 (en) Process for the detection of bacteria, yeasts, parasites and other eurcaryotes especially in foodstuffs
EP1495119B1 (en) Method and apparatus for extracting nucleic acids from a complex mixture
CA2311429A1 (en) Method and device for disintegrating biological cells for the purpose of extracting and analyzing cell contents
WO1992000384A1 (en) Improved in vitro enzymatic amplification method
WO1986004059A1 (en) Method for extracting carotene from carrots and carotene concentrate thus obtained
JP2000516473A (en) Biodegradation of explosives
CA2426698C (en) Method for producing proteins by electroporation
FR2710920A1 (en) Process for extracting nucleic acids and process for detecting specified nucleic acid sequences
FR2779741A1 (en) PROCESS FOR TREATING SUGAR BEETS
WO2012143661A1 (en) Method for quantifying living bacteria in a liquid medium
EP3004890B1 (en) Method for characterising a biological sample by tandem mass spectrometry
Jüttner [36] Carotene oxygenase in Microcystis
WO1993015222A1 (en) Method for preventing contamination, in particular in dna and rna amplification techniques
EP2362913A1 (en) Method and device for electrowetting genetic analysis
US20020042078A1 (en) Method for testing the sterility of, in particular, liquid media
WO2000009747A1 (en) Method for separating and characterising functions potentially present in a biological sample containing nucleic acids
FR2786787A1 (en) METHOD OF IN VITRO ANALYSIS OF A KNOWN PHENOTYPE FROM A SAMPLE OF NUCLEIC ACIDS
EP2917370A1 (en) Electrochemical method for denaturing or hybridising nucleic acid molecules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1999500345

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA